Royal Bank of Canada
IDXX icon

Royal Bank of Canada’s Idexx Laboratories IDXX Stock Holding History

Royal Bank of Canada’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,000
Closed -$4.02M – 7301
2023
Q2 		$4.02M Buy
+8,000
New +$3.83M ﹤0.01% 2266

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada's IDXX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Idexx Laboratories (IDXX) stake by 1.7% in Q1 2026, selling an estimated $4.24M and leaving 391,704 shares worth $220M. The position accounts for 0.04% of the portfolio, ranked #381.

Royal Bank of Canada first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $269M in Q4 2025. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Royal Bank of Canada held 391,704 shares of Idexx Laboratories worth $220M as of Q1 2026.
  • Royal Bank of Canada sold 6,619 Idexx Laboratories shares in Q1 2026, an estimated $4.24M.
  • Idexx Laboratories made up 0.04% of Royal Bank of Canada's portfolio in Q1 2026, its #381 holding.
  • Royal Bank of Canada first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Idexx Laboratories position peaked at $269M in Q4 2025.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.